Meta tag

Pd-l1

2 articles

db#1622

Cancer vaccine’s narrow failure pushes IO Biotech into bankruptcy

A Phase 3 cancer vaccine trial’s undisclosed ‘narrow failure’ last August erased IO Biotech’s $127M IPO and forced a Tuesday SEC bankruptcy filing.

01 Apr 2026

Engineered Bacteria and the Orbital Frontier: Rethinking Immunotherapy for Spaceflight

MedicineRewritten

db#3020

Engineered bacteria for tumors may point toward medicine built for space

In 2019, Georg Schett at Friedrich-Alexander University Erlangen-Nürnberg achieved durable remission in a systemic lupus erythematosus patient using CAR-T therapy — a result that launched a global research expansion beyond oncology.

18 Mar 2026